We are live on ! Find out more
BHVN icon

Biohaven

254 hedge funds and large institutions have $4.31B invested in Biohaven in 2024 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 78 increasing their positions, 80 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $94.5M | Put options by funds: $40.5M

126% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 23

50% more capital invested

Capital invested by funds: $2.88B → $4.31B (+$1.43B)

29% more funds holding in top 10

Funds holding in top 10: 79 (+2)

13% more funds holding

Funds holding: 225254 (+29)

3% less repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 80

2.58% less ownership

Funds ownership: 93.73%91.15% (-2.6%)

Holders
254
Holders Change
+29
Holders Change %
+12.89%
% of All Funds
3.65%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.13%
New
52
Increased
78
Reduced
80
Closed
23
Calls
$94.5M
Puts
$40.5M
Net Calls
+$54M
Net Calls Change
+$40.3M
Name Holding Trade Value Shares
Change
Change in
Stake
VOYA Investment Management
26
VOYA Investment Management
Georgia
$36M +$2.42M +62,125 +9%
OIM
27
Oracle Investment Management
Connecticut
$35.2M +$187K +4,800 +0.7%
Northern Trust
28
Northern Trust
Illinois
$33.8M +$1.93M +49,619 +8%
Capital International Investors
29
Capital International Investors
California
$33.6M
Goldman Sachs
30
Goldman Sachs
New York
$32.1M -$3.38M -86,783 -12%
Charles Schwab
31
Charles Schwab
California
$31.6M +$1.27M +32,769 +5%
N
32
Nuveen
North Carolina
$29.6M +$290K +7,462 +1%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$28.9M +$1.45M +37,297 +7%
Morgan Stanley
34
Morgan Stanley
New York
$28.2M -$6.03M -154,925 -22%
American Century Companies
35
American Century Companies
Missouri
$25.5M -$29.6K -762 -0.1%
UBS AM
36
UBS AM
Illinois
$25.4M +$16.8M +431,954 +563%
ClearBridge Investments
37
ClearBridge Investments
New York
$23.9M -$4.67K -120 -0%
5VM
38
5AM Venture Management
California
$23.9M +$350K +9,000 +2%
APM
39
Avidity Partners Management
Texas
$23.2M +$584K +15,000 +3%
CAM
40
Cormorant Asset Management
Massachusetts
$20.1M -$15.6M -400,000 -50%
EAM
41
Eventide Asset Management
Massachusetts
$20M -$9.14M -234,837 -37%
Marshall Wace
42
Marshall Wace
United Kingdom
$18.6M +$10.4M +266,101 +252%
Victory Capital Management
43
Victory Capital Management
Texas
$18.2M +$5.68M +145,960 +67%
Ameriprise
44
Ameriprise
Minnesota
$18.2M +$3.9M +100,201 +38%
BW
45
Bison Wealth
Georgia
$16.5M +$110K +2,840 +0.9%
TD Asset Management
46
TD Asset Management
Ontario, Canada
$15.9M +$584K +15,000 +5%
FTM
47
First Turn Management
California
$15.8M -$1.95M -50,203 -14%
Pictet Asset Management
48
Pictet Asset Management
Switzerland
$15.3M +$6.71M +172,530 +128%
SL
49
Siren LLC
Connecticut
$14.2M +$11M +283,540 New
Two Sigma Investments
50
Two Sigma Investments
New York
$14M -$2.23M -57,225 -17%

BHVN Hedge Fund Activity: Q3 2024 in Review

254 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q3 2024, worth a combined $4.31B — up 50% from $2.88B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new BHVN positions and 23 closed out — a net gain of 29 holders — while 78 added to existing stakes and 80 trimmed.

The largest buyer was Farallon Capital Management, adding an estimated $54.3M. The largest seller was Holocene Advisors, cutting an estimated $32.8M.

  • 254 institutional investors held Biohaven (BHVN) as of Q3 2024, up from 225 in Q2 2024.
  • Funds reported $4.31B of Biohaven stock for Q3 2024, up 50% quarter-over-quarter.
  • 52 funds opened new Biohaven positions in Q3 2024 and 23 closed out, a net change of +29 holders.
  • The largest Biohaven buyer in Q3 2024 was Farallon Capital Management, an estimated $54.3M added.
  • The largest Biohaven seller in Q3 2024 was Holocene Advisors, an estimated $32.8M sold.

Based on aggregated 13F filings for Q3 2024.